« Back to Record
Di Leo, A., Gancberg, D., Larsimont, D., Tanner, M., Järvinen, T., Rouas, G., Dolci, S., Leroy, J.-Y., Paesmans, M., Isola, J., & Piccart-Gebhart, M. (2002). HER-2 amplification and topoisomerase IIα gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil. Clinical cancer research, 8(5), 1107-1116.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84204



